战略重组和重新规划

Search documents
Mersana Therapeutics(MRSN) - 2025 Q1 - Earnings Call Transcript
2025-05-15 13:00
Mersana Therapeutics (MRSN) Q1 2025 Earnings Call May 15, 2025 08:00 AM ET Speaker0 Good morning, and welcome to the Mersana Therapeutics First Quarter twenty twenty five Conference Call. Currently, all participants are in a listen only mode. There will be a question and answer session at the end of this call. I would now like to turn the call over to Mr. Jason Fredett, Senior Vice President, Investor Relations and Corporate Communications. Please proceed, sir. Speaker1 Thank you, operator, and good morning ...